Key Points
- Intuitive Surgical EVP Gary Loeb sold 400 shares for $183,260 at an average price of $458.15; the sale was made under a pre-arranged Rule 10b5-1 plan. He retained 6,236 shares.
- The company reported quarterly EPS of $3.00, topping the $2.65 consensus, and revenue of $3.05 billion, up 21.7% year over year.
- Analysts give the stock a consensus “Moderate Buy” rating, with an average price target of $493.54.
Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, November 10th. The stock was sold at an average price of $458.15, for a total transaction of $183,260.00. Following the sale, the executive vice president owned 6,236 shares in the company, valued at approximately $2,857,023.40. This represents a 6.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Intuitive Surgical Price Performance
ISRG opened at $439.89 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The company's 50 day moving average price is $416.12 and its two-hundred day moving average price is $430.38. The firm has a market capitalization of $152.48 billion, a price-to-earnings ratio of 53.19, a PEG ratio of 3.10 and a beta of 1.45.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.35. The firm had revenue of $3.05 billion during the quarter, compared to the consensus estimate of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The company's revenue for the quarter was up 21.7% on a year-over-year basis. During the same quarter last year, the firm earned $2.40 earnings per share. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.
Institutional Investors Weigh In On Intuitive Surgical
Several institutional investors and hedge funds have recently made changes to their positions in the business. Bank of America Corp DE grew its stake in Intuitive Surgical by 3.3% during the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider's stock worth $1,667,388,000 after purchasing an additional 116,292 shares during the period. Bank of New York Mellon Corp bought a new stake in Intuitive Surgical in the second quarter worth approximately $1,335,753,000. Amundi increased its holdings in Intuitive Surgical by 8.6% in the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider's stock worth $1,119,448,000 after purchasing an additional 193,096 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in Intuitive Surgical by 95.3% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider's stock valued at $970,635,000 after buying an additional 1,027,475 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. lifted its stake in Intuitive Surgical by 10.8% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider's stock valued at $769,948,000 after buying an additional 184,044 shares during the period. Institutional investors own 83.64% of the company's stock.
Analyst Ratings Changes
Several brokerages recently weighed in on ISRG. BTIG Research reissued a "buy" rating and issued a $454.00 price objective on shares of Intuitive Surgical in a research note on Wednesday, October 21st. JPMorgan Chase & Co. raised their target price on Intuitive Surgical from $450.00 to $475.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 21st. Wells Fargo & Company reaffirmed an "overweight" rating and set a $486.00 target price (down from $487.00) on shares of Intuitive Surgical in a report on Wednesday, October 21st. Royal Bank Of Canada cut their target price on Intuitive Surgical from $575.00 to $550.00 and set an "outperform" rating on the stock in a report on Wednesday, October 21st. Finally, Wall Street Zen upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Saturday, October 31st. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $493.54.
Get Our Latest Research Report on ISRG
Intuitive Surgical Company Profile
(
Get Free Report)
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
